www.syros.com. As previously reported, on January 6, 2025 the Company received deficiency letters from the Listing Qualifications Department of Nasdaq providing notice that the Company was out of ...

Syros Pharmaceuticals, which said in November it would cut most of its workforce, said on Friday it will wind down operations. The company's stock dropped 45% to 8 cents in after-hours trading ...

I could go on about these quirks ... option on the top variants at a cost of Rs 80,000 more. A fully-kitted out Syros would cost as much as the mid-variants of larger SUVs like Kia’s own ...

Explore Syros Pharmaceuticals stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for SYRS. US Stocks Likely To Open Higher As Wall Street Watches Trump Tariff ...

Syros Pharmaceuticals, Inc. engages in the development of gene control therapies for cancer and diseases. Its product candidates include SY-1425, SY-2101, and SY-5609. The company was founded by ...

Kia Syros review dashboard (Image: Express Drives) That said, customers have to shell out an additional Rs 80,000 to avail the ADAS suite. Other notable safety features include six airbags ...

Out of the total bookings, 67 percent of buyers preferred the 1-litre turbo-petrol engine over the 1.5-litre diesel. Meanwhile, 46 percent of Syros customers opted for top-end trims. Aurora Black ...

Kia Syros vs Skoda Kylaq: Engine options The Kia Syros gets two engine options – a 1.0-litre, 3-cylinder, turbo-petrol which puts out 120hp of power and 172Nm torque. It comes paired with either ...

On the other hand, the Syros stands out with its boxy SUV design inspired ... Should we wait for Volkswagen Taigun or we can go and buy a Kia Seltos? Which car is best between Kia Syros vs ...

Syros Pharmaceuticals, Inc. (NASDAQ:SYRS) (the “Company”) today announced that its Board of Directors (the “Board”) has approved and the Company intends to proceed with the voluntary ...